SBC Medical EPS SBC
Diluted earnings per share by quarter and over the last twelve months, from 2022.
- Last 12 months, to Jun 30, 2026
- $0.47
- Latest quarter, Q2 FY26
- $0.10
- +400% on a year earlier
- Fiscal year 2025
- $0.49
- +0% on the year before
SBC Medical's earnings per share was $0.47 over the twelve months to Jun 30, 2026, up 47% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.10, up 400% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.49 | +0% |
| FY2024 | $0.49 | +513% |
| FY2023 | $0.08 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.10 | +400% | $0.47 | |
| Q1 FY26 | $0.11 | −48% | $0.39 | |
| Q4 FY25 | $0.14 | +133% | $0.49 | |
| Q3 FY25 | $0.12 | +300% | $0.41 | |
| Q2 FY25 | $0.02 | −90% | $0.32 | |
| Q1 FY25 | $0.21 | +5% | $0.50 | |
| Q4 FY24 | $0.06 | n/a | $0.49 | |
| Q3 FY24 | $0.03 | −67% | $0.36 | |
| Q2 FY24 | $0.20 | +900% | $0.42 | |
| Q1 FY24 | $0.20 | +400% | $0.24 | |
| Q4 FY23 | −$0.07 | n/a | $0.08 | |
| Q3 FY23 | $0.09 | n/a | n/a |
Against its peers
Companies in Medical - Care Facilities nearest SBC Medical's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| SBCSBC Medical | $0.47 | +47% a year |
| VMDViemed Healthcare | $0.36 | +6% a year |
| OMDAOmada Health | $0.06 | |
| USPHU S Physical Therapy | $0.88 | −63% a year |
| PNTGPennant | $0.90 | +15% a year |
| ARDTArdent Health | $0.55 | −70% a year |
| HCSGHealthcare Services | $1.72 | +176% a year |
| PGNYProgyny | $0.92 | +56% a year |
| ADUSAddus HomeCare | $5.70 | +26% a year |
| MDPediatrix Medical | $2.09 | +62% a year |
| PRVAPrivia Health | $0.21 | +91% a year |
| Peer median | $0.89 |
Where SBC Medical ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on SBC Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.